Results 111 to 120 of about 20,925 (217)
AIM: To estimate the incidence of secondary lactase deficiency (SLD) in patients with postinfectious irritable bowel syndrome (PIBS) and the value of the small bowel microflora in its development and to elaborate treatment options for SLD/MATERIAL AND ...
I N Ruchkina +7 more
doaj
"Syndrome and Bacterial Overgrowth in the Small Intestine"
openaire +1 more source
ABSTRACT Dedifferentiated liposarcoma (DDLPS) is an aggressive malignant soft tissue tumor comprising approximately 15%–20% of all liposarcomas. When presenting in the extremities, its atypical clinical and radiological features may mimic vascular or infectious conditions, posing a serious diagnostic challenge that can delay curative intervention. A 60‐
Rashid Shahriar Sazal +5 more
wiley +1 more source
The intestinal microbiome is a key regulator of immune homeostasis, metabolism, and epithelial barrier integrity. In patients with malignant hematological diseases, particularly those undergoing hematopoietic stem cell transplantation, microbiome perturbations by reduced diversity, pathobiont expansion, and loss of beneficial metabolites are common as ...
Bálint Gergely Szabó +7 more
wiley +1 more source
Maternal consumption of diacylglycerol (DAG) oil attenuates high‐fat diet (HFD)‐induced obesity and dyslipidemia in mother mice and their male offspring. DAG restored purine/pyrimidine metabolism, maintained mitochondrial morphology, suppressed the DAG‐PKCβ/PKD1‐NF‐κB pathway, and promoted fatty acid oxidation (CPT1A↑, ACSS2↓).
Qiu Wu +7 more
wiley +1 more source
Selected orally administered probiotics and functional‐food interventions may alter gut microbial ecology and intestinal barrier function. Microbiota‐derived metabolites, microbial components, and endocrine signals—including short‐chain fatty acids, bile acids, tryptophan metabolites, and lipopolysaccharide—may influence systemic immune, metabolic, and
Meiqi Chen +6 more
wiley +1 more source
High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome
John JolleyDepartment of Medicine, University of California, San Francisco, CA, USABackground: To evaluate the efficacy of rifaximin for reduction of gastrointestinal symptoms in patients with irritable bowel syndrome (IBS).Methods: Medical records were ...
Jolley J
doaj
ABSTRACT Background Persistent gas‐predominant dyspeptic symptoms affect many patients despite adequate proton pump inhibitor (PPI) therapy, reflecting mechanisms beyond acid secretion. We evaluated the real‐world effectiveness and safety of simethicone (80 mg) plus activated charcoal (250 mg) in adults with persistent symptoms despite prior PPI ...
Ashish Kumar +11 more
wiley +1 more source
Effectiveness of the low FODMAP diet in patients with irritable bowel syndrome and small intestine bacterial overgrowth syndrome. [PDF]
Bogdanowska-Charkiewicz D +6 more
europepmc +1 more source
Suppurative nevus comedonicus (SNC) is a variant of nevus comedonicus in which the characteristic features coexist with recurrent inflammatory lesions that clinically resemble those of hidradenitis suppurativa (HS). We present the ultrasound characteristics of this entity and emphasize the value of high‐resolution dermatologic ultrasound both as a ...
Marta Ivars +4 more
wiley +1 more source

